PMID: 9159404Jan 1, 1997Paper

Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan

Microbiology and Immunology
K KusuharaT Osato

Abstract

In order to evaluate the possibility of Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6) transmission via breast milk, a total of 331 serum specimens collected from bottle-fed and breast-fed children and their mothers, in 2 endemic areas of human T-cell lymphotropic virus type I (HTLV-I) in Japan, were assayed for antibodies to EBV and HHV-6. The seroprevalences of EBV and HHV-6 were over 95% both in the mothers of bottle-fed children and in those of breast-fed children. The seroprevalence of EBV at 12-23 months of age was 54.5% (36/66) and 55.8% (24/43) in breast-fed children and bottle-fed children, respectively. The seroprevalence of HHV-6 at 12-23 months of age was 90.9% (60/66) and 93.0% (40/43) in breast-fed children and bottle-fed children, respectively. No difference was observed between the seroprevalences of EBV and HHV-6 in breast-fed and bottle-fed children at 12-23 months of age. Our seroepidemiologic data indicate that breast milk is not a significant source of early EBV or HHV-6 infection in infancy.

References

Sep 15, 1978·International Journal of Cancer. Journal International Du Cancer·R J BiggarG Henle
Oct 1, 1991·The American Journal of the Medical Sciences·A K JunkerL Rymo
Jan 1, 1991·The Journal of Infection·D SanyalM Young
Feb 1, 1990·Journal of Medical Virology·G B HarnettM R Bucens
Aug 1, 1990·The Pediatric Infectious Disease Journal·T YoshikawaT Ozaki
Sep 1, 1990·Journal of Medical Virology·R F JarrettD E Onions
Nov 1, 1990·Journal of Medical Virology·S KidoK Yamanishi
Apr 1, 1989·Journal of Clinical Microbiology·T OkunoK Baba
Jun 25, 1988·Lancet·K TakahashiK Kamanishi
Apr 1, 1989·The Journal of Infectious Diseases·K UedaK Yamanishi
Jul 27, 1972·The New England Journal of Medicine·K HayesI Jack
Dec 20, 1973·The New England Journal of Medicine·R S ChangC F Abildgaard
May 8, 1980·The New England Journal of Medicine·S StagnoC A Alford
Jan 1, 1994·Microbiology and Immunology·I MinamishimaK Kuraya
Jul 1, 1993·The Journal of Infectious Diseases·W M Dunne, M Jevon

❮ Previous
Next ❯

Citations

Aug 4, 2001·The American Journal of Pathology·P G ChuL M Weiss
Aug 19, 1999·Journal of the National Cancer Institute·M BonnetI Joab
Apr 24, 2001·Archives of Disease in Childhood·C A Michie, J Gilmour
Jun 17, 2008·The Journal of Molecular Diagnostics : JMD·Margaret L Gulley, Weihua Tang
Apr 6, 2016·International Journal of Dentistry·Razia Abdool Gafaar KhammissaLiviu Feller
Oct 14, 2004·The Journal of Pediatrics·Robert F Pass
Mar 13, 2015·Clinical Microbiology Reviews·Henri AgutAgnès Gautheret-Dejean
Feb 19, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ana Montoya-FerrerEdouard Tuaillon
Jun 24, 2016·Microbiology Spectrum·Henri AgutAgnès Gautheret-Dejean

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.